Power to overcome
|This is your direct access to ONE-TO-ONE sessions with technical experts covering the most promising advances in medical technology.|
Heart Rhythm 2021: Technical Virtual Appointments
Schedule your exclusive virtual appointment to talk one-to-one with a technical expert about our most advanced current (and future) technologies that Boston Scientific has to offer. Available to healthcare professionals only.
Select appointment topic
The INTELLANAV STABLEPOINT™ Ablation Catheter, enabled with DIRECTSENSE™ Technology, combines the power of contact force and local impedance to give dynamic insights at and below the cardiac tissue surface. The integrated solution, available exclusively via RHYTHMIA HDx™, enables you to diagnose, ablate and validate with more critical information than ever before.
Cryoablation, redesigned. POLARx™ builds on the established approach and performance of current cryoablation technologies for AF ablation. However, it is engineered to include physician-driven enhancements to address the known limitations with existing technologies.
The LUX-Dx™ ICM System has been designed to deliver on the promise of an ICM to address the unmet needs of physicians, clinicians, and patients. We are looking for your input on how we continue to improve and meet your current cardiac diagnostics needs now and in the future.
EMBLEMTM S-ICD is the only ICD in the world to provide protection from both sudden cardiac death and the risks and complications associated with transvenous leads. The modular CRM system consists of the S-ICD and EMPOWER™ Leadless Pacemaker, which are designed to work together to coordinate therapy.
HeartLogic™ Heart Failure Diagnostic is a personalized, remote heart failure diagnostic and monitoring solution only found in Boston Scientific ICDs and CRT-Ds. Using multiple, novel physiologic sensors with high sensitivity and low alert burden, it’s validated to provide weeks of advance notice for detecting early signs of worsening heart failure.1
The LATITUDE™ portfolio of patient management solutions work together to help you improve patient outcomes, increase clinical efficiencies and seamlessly transfer data to your electronic medical record (EMR).
This session will provide an overview of Boston Scientific's Brady/Tachy/ Heart Failure devices and leads.
Boston Scientific Confidential Disclosure Agreement
During your virtual appointment, you will be the Recipient of Boston Scientific Confidential Information. By scheduling and/or participating in a virtual appointment, you agree to the terms and conditions of the Boston Scientific Confidential Disclosure Agreement. Upon accessing the virtual appointment calendar page, you will have access to the Boston Scientific Confidential Disclosure Agreement and will have the opportunity to READ, ACCEPT, and AGREE to its terms and conditions as a pre-requisite to making or attending your virtual appointment. To view the Boston Scientific Confidential Disclosure Agreement, bearing the title, “BSC CDA Out Virtual Appointment July 2, 2021”, click here.
Stay Up to Date
Receive emails on the latest news from Boston Scientific.
*Investigational Device. Limited by US law to investigational use only. Not available for sale.
CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician. Rx only. Prior to use, please see the complete "Directions for Use" for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator's Instructions.
1Boehmer JP, Hariharan R, Devecchi FG, et al. A Multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail. 2017 Mar;5(3):216-25.